Rare Subtypes of Gastrointestinal Cancers

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAarhus University Hospital

About this trial

A single-arm prospective observational translational study of biomarkers in patients receiving targeted treatment for rare subtypes of cancer of the Gastrointestinal Tract.

Eligibility criteria

Qualifiers

Diagnosis of a rare subtype of GI cancer including BRAF V600E mutation, MSI-H, HER2 and others

Diagnosis of cancer of the gastrointestinal tract may be made by histo- or cyto-pathology, or by clinical and imaging criteria

Planned for targeted treatment

Age 18 years or older

Disqualifiers

Conditions precluding translational blood sampling

Another concomitant cancer

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators